CE
Celanese Corp
$
54.140
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
56.990
Open
56.760
VWAP
--
Vol
1.64M
Mkt Cap
5.92B
Low
53.600
Amount
--
EV/EBITDA(TTM)
10.36
Total Shares
109.22M
EV
18.49B
EV/OCF(TTM)
20.50
P/S(TTM)
0.62
Celanese Corporation is a global chemical and specialty materials company. The Company is a global producer of engineered polymers that are used in a variety of applications. Its segments include Engineered Materials and the Acetyl Chain. The Company's Engineered Materials segment includes the engineered materials business and certain strategic affiliates. The Engineered Materials business develops, produces and supplies a broad portfolio of high-performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. The Company's Acetyl Chain segment includes the integrated chain of acetic acid, vinyl acetate monomer (VAM), acetic anhydride, acetate esters, emulsion polymers, ethylene vinyl acetate (EVA) polymers, redispersible powders (RDP), and acetate tow businesses. The Acetyl Chain business produces and supplies acetyl products, including acetic acid, VAM, acetic anhydride and acetate esters.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
2.39B
+0.86%
1.449
-0.07%
2.58B
-2.61%
1.728
-29.19%
2.50B
-5.75%
1.401
-41.15%
Estimates Revision
The market is revising Upward the revenue expectations for Celanese Corporation (CE) for FY2025, with the revenue forecasts being adjusted by 2.02% over the past three months. During the same period, the stock price has changed by 21.64%.
Revenue Estimates for FY2025
Revise Upward
+2.02%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-0.27%
In Past 3 Month
Stock Price
Go Up
+21.64%
In Past 3 Month
13 Analyst Rating
17.29% Upside
Wall Street analysts forecast CE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CE is 63.50 USD with a low forecast of 47.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
9 Hold
0 Sell
Moderate Buy
17.29% Upside
Current: 54.140
Low
47.00
Averages
63.50
High
76.00
17.29% Upside
Current: 54.140
Low
47.00
Averages
63.50
High
76.00
Mizuho
Neutral
maintain
$50 -> $59
2025-07-15
Reason
Mizuho
Price Target
$50 -> $59
2025-07-15
maintain
Neutral
Reason
Mizuho raised the firm's price target on Celanese to $59 from $50 and keeps a Neutral rating on the shares. The firm updated price targets in chemicals and packaging ahead of the Q2 reports. It says the new targets reflect the recent market multiple recovery. Mizuho's top picks are all specialty and defensive names: Corteva (CTVA), Crown (CCK) and Linde (LIN). A pause in tariffs likely pulled forward some demand, which could create a year-end slowdown, the analyst tells investors in a research note.
Citi
Neutral -> Hold
upgrade
$52 -> $68
2025-07-10
Reason
Citi
Price Target
$52 -> $68
2025-07-10
upgrade
Neutral -> Hold
Reason
Citi raised the firm's price target on Celanese to $68 from $52 and keeps a Neutral rating on the shares. The firm has a mixed view on chemicals heading into the Q2 reports given tariff uncertainty. It believes macro headwinds weighed on demand and drove Q2 volumes below expectations.
Citi
Neutral
maintain
$52 -> $65
2025-07-10
Reason
Citi
Price Target
$52 -> $65
2025-07-10
maintain
Neutral
Reason
Citi raised the firm's price target on Celanese to $65 from $52 and keeps a Neutral rating on the shares. The firm has a mixed view on chemicals heading into the Q2 reports given tariff uncertainty. It believes macro headwinds weighed on demand and drove Q2 volumes below expectations.
UBS
Neutral
maintain
$51 -> $66
2025-07-09
Reason
UBS
Price Target
$51 -> $66
2025-07-09
maintain
Neutral
Reason
UBS raised the firm's price target on Celanese to $66 from $51 and keeps a Neutral rating on the shares.
RBC Capital
Arun Viswanathan
Sector Perform
maintain
$53 -> $63
2025-07-03
Reason
RBC Capital
Arun Viswanathan
Price Target
$53 -> $63
2025-07-03
maintain
Sector Perform
Reason
RBC Capital analyst Arun Viswanathan raised the firm's price target on Celanese to $63 from $53 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 results among select Chemicals names. Recent conversations with investor relations teams have generally shown that demand has remained somewhat tepid through Q2, while Building and Construction activity has been somewhat muted, the analyst tells investors in a research note. The ongoing tariff uncertainty has weighed on export markets, which has resulted in North America polyurethane markets being backed up, with continued price pressure expected in the near-term, and Durables demand has yet to see a material recovery, RBC added.
Wells Fargo
Equal Weight -> Overweight
upgrade
$45 -> $66
2025-06-17
Reason
Wells Fargo
Price Target
$45 -> $66
2025-06-17
upgrade
Equal Weight -> Overweight
Reason
Wells Fargo upgraded Celanese to Overweight from Equal Weight with a price target of $66, up from $45. The firm sees potential for sequential earnings improvement on cost savings and reduced maintenance and notes its outlook assumes no demand improvement near term. The stock stock is down 70% from its high just over a year ago and is currently trading at 7.5-times mid-cycle EBITDA of $2.5B, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Celanese Corp (CE.N) is 10.05, compared to its 5-year average forward P/E of 10.25. For a more detailed relative valuation and DCF analysis to assess Celanese Corp 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
10.25
Current PE
10.05
Overvalued PE
12.12
Undervalued PE
8.37
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Fair
5Y Average EV/EBITDA
8.66
Current EV/EBITDA
9.16
Overvalued EV/EBITDA
10.26
Undervalued EV/EBITDA
7.06
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
1.46
Current PS
0.64
Overvalued PS
1.98
Undervalued PS
0.93
Financials
Annual
Quarterly
FY2025Q1
YoY :
-8.50%
2.39B
Total Revenue
FY2025Q1
YoY :
-18.22%
175.00M
Operating Profit
FY2025Q1
YoY :
-109.68%
-12.00M
Net Income after Tax
FY2025Q1
YoY :
-117.27%
-0.19
EPS - Diluted
FY2025Q1
YoY :
+80.56%
-65.00M
Free Cash Flow
FY2025Q1
YoY :
-7.12%
18.25
Gross Profit Margin - %
FY2025Q1
YoY :
-65.68%
4.99
FCF Margin - %
FY2025Q1
YoY :
-110.53%
-0.50
Net Margin - %
FY2025Q1
YoY :
-100.00%
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
1.2M
USD
2
Bought
0-3
1
77.2K
USD
Months
3-6
5
697.5K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
3
1.8M
Volume
Months
6-9
2
2.8M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
1.2M
USD
2
Bought
0-3
1
77.2K
USD
Months
3-6
5
697.5K
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CE News & Events
Events Timeline
2025-05-05 (ET)
2025-05-05
17:21:52
Celanese announces Engineered Materials price Increases
2025-05-05
16:58:32
Celanese sees Q2 adjusted EPS $1.30-$1.50, consensus $1.39
2025-05-05
16:56:45
Celanese reports Q1 adjusted EPS 57c, consensus 39c
Sign Up For More Events
Sign Up For More Events
News
3.5
07-29NewsfilterBentley Mills Becomes Early Adopter of Celanese ECO-CC Binder To Advance Sustainable Carpet Tile Manufacturing
7.5
07-29NewsfilterMeliodays and Celanese Partner for Meliodays' Development of Hormone-Free Non-Contraceptive IUD designed to Treat Menstrual Pain
8.0
07-25NASDAQ.COMCash Dividend On The Way From Celanese (CE)
Sign Up For More News
People Also Watch
BIO
Bio Rad Laboratories Inc
250.080
USD
-1.00%
AM
Antero Midstream Corp
17.140
USD
+0.94%
HII
Huntington Ingalls Industries Inc
258.520
USD
-0.89%
ENSG
Ensign Group Inc
150.380
USD
-0.42%
ABEV
Ambev SA
2.300
USD
-1.71%
AXTA
Axalta Coating Systems Ltd
28.670
USD
-0.10%
VNO
Vornado Realty Trust
38.590
USD
-2.67%
KBR
KBR Inc
45.520
USD
-2.28%
FAQ
What is Celanese Corp (CE) stock price today?
The current price of CE is 54.14 USD — it has decreased -4.97 % in the last trading day.
What is Celanese Corp (CE)'s business?
What is the price predicton of CE Stock?
What is Celanese Corp (CE)'s revenue for the last quarter?
What is Celanese Corp (CE)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Celanese Corp (CE)'s fundamentals?
How many employees does Celanese Corp (CE). have?